ACADIA Pharmaceuticals In... (ACAD)
undefined
undefined%
At close: undefined
17.45
-0.11%
After-hours Jan 06, 2025, 06:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY00
Net Income -61.29M -215.97M -167.87M -281.58M -235.26M -245.19M -289.40M -271.39M -164.44M -92.47M -37.95M -20.85M -22.77M 15.14M -45.15M -64.24M -56.39M -45.05M -34.14M -25.92M -14.09M -12.87M -10.19M
Depreciation & Amortization 5.55M 2.03M 3.34M 2.93M 2.77M 3.00M 2.71M 1.83M 647.00K 206.00K 79.00K 109.00K 285.00K 607.00K 1.11M 1.04M 768.00K -146.00K 1.03M 1.31M 1.34M 1.40M n/a
Stock-Based Compensation 66.42M 68.20M 63.62M 84.42M 82.27M 81.56M 75.53M 55.27M 40.19M 16.04M 5.71M 1.93M 1.60M 1.58M 2.13M 2.99M 3.38M 3.38M 1.31B 2.36B n/a n/a n/a
Other Working Capital 81.41M 27.54M -2.88M 25.55M 11.08M 4.24M 1.17M 11.36M 4.46M 7.67M -126.00K -1.85M 103.00K -26.83M 26.93M -5.29M -4.76M -740.00K 90.89M -576.05M 1.54M 1.06M n/a
Other Non-Cash Items -12.12M -6.28M 75.00K 44.28M -4.61M 1.35M -287.00K 94.00K -2.06M 484.00K 1.52M -385.00K 806.00K -211.00K 583.00K 5.00K 4.29M 3.38M 1.46M 2.36M 1.39M 1.16M -15.14M
Deferred Income Tax n/a n/a n/a 2.75M n/a n/a n/a -596.00K -247.00K n/a n/a n/a 105.00K n/a n/a 911.00K -3.53M -3.55M -1.31B -2.36B n/a n/a n/a
Change in Working Capital 18.13M 37.99M -24.82M 11.04M 3.71M -8.20M -6.41M 4.39M 4.11M 9.31M -1.13M -2.44M 74.00K -27.82M 27.59M -5.57M -3.44M 574.00K 11.39M 1.55M 1.54M 1.06M 25.33M
Operating Cash Flow 16.70M -114.03M -125.66M -136.17M -151.13M -167.47M -217.86M -210.41M -121.80M -66.43M -31.77M -21.63M -19.90M -10.70M -13.73M -64.87M -54.93M -41.42M -20.26M -20.69M -9.82M -9.24M n/a
Capital Expenditures -40.05M n/a -1.12M -7.59M -1.13M -2.15M -812.00K -9.51M -2.14M -180.00K -618.00K -3.00K -3.00K n/a -41.00K -226.00K -416.00K -2.03M -1.02M -585.30K -1.78M -380.60K n/a
Acquisitions -32.05M n/a 69.98M -200.10M 164.71M 44.00K n/a 8.00M -2.06M n/a n/a 3.00K 3.00K n/a n/a n/a -12.52M n/a n/a n/a n/a n/a n/a
Purchase of Investments -369.99M -363.17M -492.80M -339.91M -578.63M -331.06M -478.82M -683.36M -269.49M -335.36M -211.59M -56.73M -48.07M -54.67M -50.27M -79.97M -222.23M -116.60M -54.52M -36.65M -37.06M -11.99M n/a
Sales Maturities Of Investments 442.03M 436.42M 422.82M 540.00M 413.93M 261.68M 572.10M 430.94M 419.20M 248.27M 86.09M 30.95M 54.05M 53.49M 59.75M 149.91M 180.75M 83.17M 48.89M 29.85M 24.15M 16.22M n/a
Other Investing Acitivies 32.05M 73.24M -69.98M 200.10M -164.71M 44.00K 93.28M -8.00M 2.06M -87.09M 12.00K 252.00K -3.00K 128.00K n/a n/a 12.52M 12.52M n/a n/a n/a n/a n/a
Investing Cash Flow 32.00M 73.24M -71.10M 192.51M -165.84M -71.49M 92.47M -261.92M 147.57M -87.27M -126.10M -25.53M 5.98M -1.06M 9.44M 69.71M -41.90M -22.94M -6.65M -7.38M -14.69M 3.85M n/a
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -32.00K -78.00K -353.00K -762.00K -909.00K -379.00K 593.00K -779.70K -1.39M -1.62M 4.37M n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a n/a n/a n/a n/a n/a 14.92M -45.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a -12.52M n/a n/a n/a n/a
Financial Cash Flow 25.13M 8.20M 18.16M 81.00M 371.85M 306.65M 31.19M 533.81M 14.50M 203.85M 111.68M 98.17M 13.94M 470.00K 1.16M -374.00K 98.22M 70.00M 28.37M 30.11M 26.40M 4.39M n/a
Net Cash Flow 73.81M -32.59M -178.59M 137.33M 54.88M 67.69M -94.20M 61.48M 40.28M 50.15M -46.19M 51.01M 40.00K -11.27M -3.05M 4.18M 1.51M 5.68M 1.49M 1.99M 1.85M -1.06M n/a
Free Cash Flow -23.35M -114.03M -126.78M -143.75M -152.26M -169.62M -218.67M -219.91M -123.94M -66.61M -32.39M -21.64M -19.90M -10.70M -13.77M -65.09M -55.34M -43.44M -21.28M -21.28M -11.59M -9.62M n/a